Literature DB >> 19251171

Endoscopic therapies for the treatment of reflux disease.

Katie S Nason1, Matthew J Schuchert, Bart P L Witteman, Blair A Jobe.   

Abstract

Endoscopic techniques for the treatment of reflux disease were first introduced in 2000 as an alternative to laparoscopic antireflux operations. Because of reports of long-term treatment failure with laparoscopic fundoplication and the fact that surgery is increasingly being reserved for the relatively small proportion of patients with complicated reflux disease, attempts to develop safe, effective, and durable endoscopic approaches to antireflux surgery continue. Techniques include radiofrequency ablation, injection therapy, and suturing/stapling techniques. Of these, the suturing/stapling techniques are most similar to the anatomic restructuring of the gastroesophageal junction provided by fundoplication. While early attempts at endoscopic suturing have been disappointing, significant advances in endoscopic instrumentation, a more complete understanding of the gastroesophageal junction anatomy, and improvements in the technical skills of the endoscopic surgeon have been realized. As a result, techniques now being tested, such as the endoluminal fundoplication, may prove more effective and durable than previous endoscopic antireflux procedures.

Entities:  

Mesh:

Year:  2008        PMID: 19251171     DOI: 10.1053/j.semtcvs.2008.11.014

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  3 in total

1.  Endoscopic treatments for gastroesophageal reflux disease.

Authors:  Blair A Jobe
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-01

2.  Revisional laparoscopic antireflux surgery after unsuccessful endoscopic fundoplication.

Authors:  Bart P L Witteman; Boudewijn F Kessing; Gitte Snijders; Ger H Koek; José M Conchillo; Nicole D Bouvy
Journal:  Surg Endosc       Date:  2013-01-05       Impact factor: 4.584

3.  Antireflux endoluminal therapies: past and present.

Authors:  Kuo Chao Yew; Seng-Kee Chuah
Journal:  Gastroenterol Res Pract       Date:  2013-07-09       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.